Invention Grant
- Patent Title: Steroid-containing sustained release intraocular implants and related methods
- Patent Title (中): 类固醇持续释放眼内植入物及相关方法
-
Application No.: US11118288Application Date: 2005-04-29
-
Publication No.: US08257730B2Publication Date: 2012-09-04
- Inventor: Glenn T. Huang , Thierry Nivaggioli , Lon T. Spada , Hiroshi Sugimoto , Wendy M Blanda , James N. Chang , Orest Olejnik
- Applicant: Glenn T. Huang , Thierry Nivaggioli , Lon T. Spada , Hiroshi Sugimoto , Wendy M Blanda , James N. Chang , Orest Olejnik
- Applicant Address: US CA Irvine
- Assignee: Allergan, Inc.
- Current Assignee: Allergan, Inc.
- Current Assignee Address: US CA Irvine
- Agent Louis V. Wollenberger; Joel B. German; Debra D. Condino
- Main IPC: A61F2/00
- IPC: A61F2/00

Abstract:
Biocompatible intraocular implants include a steroid and a polymer associated with each other to facilitate release of the steroid into an eye for a period of time greater than about two months. The steroid may be associated with a biodegradable polymer matrix, such as a matrix of a two biodegradable polymers. Or, the steroid may be associated with a polymeric coating having one or more openings effective to permit the steroid to be released into an external environment. The implants may be placed in an eye to treat one or more ocular conditions. The steroid is released from the implant for more than about two months, and may be release for more than several years.
Public/Granted literature
- US20050244474A1 Steroid-containing sustained release intraocular implants and related methods Public/Granted day:2005-11-03
Information query
IPC分类: